3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
64
Burkitt Lymphoma
10
Recurrence
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
4
Carcinoma, Non-Small-Cell Lung
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms, Plasma Cell
3
Lymphoma, Non-Hodgkin
3
Smoldering Multiple Myeloma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thalassemia
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Neoplasms
1
Plasmacytoma
1
Interventions
Cisplatin
12
Gemcitabine
9
Specimen Handling
6
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Drug Therapy
5
toripalimab
4
Platinum
4
Nivolumab
4
Capecitabine
4
1,2-diaminocyclohexaneplatinum II citrate
4
spartalizumab
3
Radiotherapy
3
Immune Checkpoint Inhibitors
3
sintilimab
2
Ipilimumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
tislelizumab
1
relatlimab
1
pembrolizumab
1
olaparib
1
fluciclovine F-18
1
dehydroftorafur
1
cemiplimab
1
camrelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Dexamethasone
×
30 days
×
Clear all
No trials found.